Oppenheimer Raises PT and Estimates on Cubist Pharmaceuticals (CBST); Guidance Likely Conservative
Tweet
Share
E-mailGet Alerts CBST Hot Sheet
Price: $101.94 --0%
Rating Summary:
6 Buy, 13 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
6 Buy, 13 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Oppenheimer maintains an 'Outperform' on Cubist Pharmaceuticals (NASDAQ: CBST) price target raised from $45 to $49.
Analyst, Christopher Holterhoff, said, "While we expect 1Q12 US Cubicin sales to
be generally in-line with our expectations ($187.8M), we see upside during 2012,
with Cubicin sales growth driven by increased use in the anti-staph market (14%
share as of Nov. '11) and increased usage in the outpatient setting...We anticipate modest near-term upside on Cubicin revs, with longer-term upside driven by pipeline advancements." (FY12 EPS estimate lowered slightly from $2.59 to $2.56)
For an analyst ratings summary and ratings history on Cubist Pharmaceuticals click here. For more ratings news on Cubist Pharmaceuticals click here.
Shares of Cubist Pharmaceuticals closed at $43.77 yesterday.
Analyst, Christopher Holterhoff, said, "While we expect 1Q12 US Cubicin sales to
be generally in-line with our expectations ($187.8M), we see upside during 2012,
with Cubicin sales growth driven by increased use in the anti-staph market (14%
share as of Nov. '11) and increased usage in the outpatient setting...We anticipate modest near-term upside on Cubicin revs, with longer-term upside driven by pipeline advancements." (FY12 EPS estimate lowered slightly from $2.59 to $2.56)
For an analyst ratings summary and ratings history on Cubist Pharmaceuticals click here. For more ratings news on Cubist Pharmaceuticals click here.
Shares of Cubist Pharmaceuticals closed at $43.77 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Va Tech Wabag Ltd. (VATW:IN) PT Raised to INR2,410 at ICICI Securities
- Freedom Broker Upgrades Lifeway Foods (LWAY) to Buy
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
